Expert Ratings for Tenaya Therapeutics
Portfolio Pulse from Benzinga Insights
Tenaya Therapeutics (NASDAQ:TNYA) has received positive analyst ratings in the last quarter, with 4 bullish and 1 somewhat bullish ratings. The company's average price target has increased by 16.13% from the previous average of $15.50 to $18.00.
October 09, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tenaya Therapeutics has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up.
Analyst ratings are a significant factor that investors consider when making investment decisions. The positive ratings for Tenaya Therapeutics indicate a positive outlook for the company, which could lead to increased investor interest and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100